Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
2.150
+0.090 (4.37%)
Nov 21, 2024, 4:00 PM EST - Market closed
Cocrystal Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 22 | 18 | 16 | 63 | 93 | 17 | |
| Market Cap Growth | -5.88% | 10.34% | -74.94% | -32.06% | 435.38% | -83.83% | |
| Enterprise Value | 11 | -12 | -26 | 2 | 62 | 12 | |
| Last Close Price | 2.15 | 1.72 | 1.95 | 7.80 | 16.32 | 5.95 | |
| PS Ratio | - | - | - | - | 46.30 | 2.65 | |
| PB Ratio | 1.72 | 0.66 | 0.40 | 0.82 | 1.78 | 0.68 | |
| P/TBV Ratio | 1.41 | 0.66 | 0.40 | 1.08 | 2.79 | 2.63 | |
| EV/Sales Ratio | - | - | - | - | 30.84 | 1.88 | |
| Debt / Equity Ratio | 0.15 | 0.07 | 0.01 | 0.01 | 0.01 | 0.03 | |
| Asset Turnover | - | - | - | - | 0.05 | 0.14 | |
| Quick Ratio | 7.02 | 8.35 | 31.13 | 38.00 | 24.72 | 3.53 | |
| Current Ratio | 7.32 | 8.92 | 33.04 | 38.40 | 25.05 | 3.62 | |
| Return on Equity (ROE) | -86.20% | -54.54% | -66.32% | -21.81% | -24.67% | -104.04% | |
| Return on Assets (ROA) | -51.98% | -36.68% | -18.86% | -13.30% | -14.48% | -2.96% | |
| Return on Capital (ROIC) | -55.95% | -38.84% | -19.22% | -13.55% | -15.05% | -3.07% | |
| Earnings Yield | -85.50% | -102.64% | -244.58% | -22.39% | -10.35% | -276.57% | |
| FCF Yield | -84.38% | -135.46% | -20.16% | -10.80% | -9.81% | |
| Buyback Yield / Dilution | -11.55% | -18.52% | -10.58% | -60.04% | -73.32% | -13.75% | |
| Total Shareholder Return | -11.55% | -18.52% | -10.58% | -60.04% | -73.32% | -13.75% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.